Nationwide Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-74,885
| Closed | -$33.5M | – | 1630 |
|
|
2017
Q3 | $33.5M | Sell |
74,885
-2,944
| -4% | -$1.32M | 0.13% | 150 |
|
|
2017
Q2 | $38.2M | Buy |
77,829
+24,639
| +46% | +$12.1M | 0.15% | 115 |
|
|
2017
Q1 | $20.6M | Sell |
53,190
-2,261
| -4% | -$876K | 0.08% | 308 |
|
|
2016
Q4 | $20.4M | Buy |
55,451
+865
| +2% | +$318K | 0.08% | 296 |
|
|
2016
Q3 | $21.9M | Buy |
54,586
+11,910
| +28% | +$4.79M | 0.09% | 254 |
|
|
2016
Q2 | $14.9M | Buy |
42,676
+19,101
| +81% | +$6.67M | 0.06% | 411 |
|
|
2016
Q1 | $8.5M | Sell |
23,575
-7,413
| -24% | -$2.67M | 0.04% | 654 |
|
|
2015
Q4 | $16.8M | Sell |
30,988
-34,285
| -53% | -$18.6M | 0.07% | 350 |
|
|
2015
Q3 | $30.4M | Buy |
65,273
+1,134
| +2% | +$527K | 0.14% | 157 |
|
|
2015
Q2 | $32.7M | Buy |
64,139
+4,383
| +7% | +$2.24M | 0.13% | 156 |
|
|
2015
Q1 | $27M | Sell |
59,756
-1,551
| -3% | -$700K | 0.11% | 212 |
|
|
2014
Q4 | $25.2M | Buy |
61,307
+3,700
| +6% | +$1.52M | 0.11% | 218 |
|
|
2014
Q3 | $20.8M | Sell |
57,607
-5,600
| -9% | -$2.02M | 0.09% | 276 |
|
|
2014
Q2 | $17.9M | Sell |
63,207
-15,720
| -20% | -$4.44M | 0.07% | 332 |
|
|
2014
Q1 | $23.7M | Buy |
78,927
+8,308
| +12% | +$2.49M | 0.11% | 214 |
|
|
2013
Q4 | $19.4M | Buy |
70,619
+1,727
| +3% | +$475K | 0.08% | 299 |
|
|
2013
Q3 | $21.6M | Buy |
68,892
+35,920
| +109% | +$11.2M | 0.1% | 243 |
|
|
2013
Q2 | $7.42M | Buy |
+32,972
| New | +$7.42M | 0.04% | 606 |
|